4
Changes in Ownership
Chemomab Therapeutics Ltd. Filed Acc 0001178913-22-002093
Director bought 2,000 shares at $3.19 ($6,380)
From the SEC's structured data for this filing
Trades in this filing
Cohen Neil Harris · Director
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-05-18 | Purchase : show line 1 in the form | +2,000 | $3.19 | $6,380 | 12,409 | D |
| Open-market purchases · 2,000 sh · avg $3.19 · $6,380 | ||||||
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-03-07 | Grant or award : show line 2 in the form Option to Purchase American Depositary Shares | +6,820 | 6,820 | D |
| 2021-04-19 | Grant or award : show line 3 in the form Option to Purchase American Depositary Shares | +11,884 | 11,884 | D |
| 2021-03-16 | Grant or award : show line 4 in the form Option to Purchase American Depositary Shares | +688 | 688 | D |
Loading xslF345X03/zk2227874.xml…